干旱区生态环境知识资源中心(Arid): Early and Durable Symptom Control in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Etrasimod (APD334) in the Phase 2 OASIS Trial and Open Label Extension

Arid

	Early and Durable Symptom Control in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Etrasimod (APD334) in the Phase 2 OASIS Trial and Open Label Extension
	Chiorean, Michael V.; Vermeire, Severine; Panes, Julian; Peyrin-Biroulet, Laurent; Zhang, Jinkun; Sands, Bruce E.; Cabell, Chris; Naik, Snehal; Sandborn, William J.
来源期刊	AMERICAN JOURNAL OF GASTROENTEROLOGY
ISSN	0002-9270
EISSN	1572-0241
出版年	2020
卷号	115 页码:S391-S392
类型	Meeting Abstract
语种	英语
收录类别	SCI-E
WOS记录号	WOS:000607196702068
WOS类目	Gastroenterology & Hepatology
WOS研究方向	Gastroenterology & Hepatology
资源类型	期刊论文
条目标识符	http://119.78.100.177/qdio/handle/2XILL650/348708
作者单位	[Chiorean, Michael V.] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Vermeire, Severine] Univ Hosp Leuven, Leuven, Vlaams Brabant, Belgium; [Panes, Julian] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Catalonia, Spain; [Peyrin-Biroulet, Laurent] Nancy Univ Hosp, Nancy, Lorraine, France; [Zhang, Jinkun; Cabell, Chris; Naik, Snehal] Arena Pharmaceut, San Diego, CA USA; [Sands, Bruce E.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Sandborn, William J.] Univ Calif San Diego, La Jolla, CA 92093 USA
推荐引用方式 GB/T 7714	Chiorean, Michael V.,Vermeire, Severine,Panes, Julian,et al. Early and Durable Symptom Control in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Etrasimod (APD334) in the Phase 2 OASIS Trial and Open Label Extension[J],2020,115:S391-S392.
APA	Chiorean, Michael V..,Vermeire, Severine.,Panes, Julian.,Peyrin-Biroulet, Laurent.,Zhang, Jinkun.,...&Sandborn, William J..(2020).Early and Durable Symptom Control in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Etrasimod (APD334) in the Phase 2 OASIS Trial and Open Label Extension.AMERICAN JOURNAL OF GASTROENTEROLOGY,115,S391-S392.
MLA	Chiorean, Michael V.,et al."Early and Durable Symptom Control in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Etrasimod (APD334) in the Phase 2 OASIS Trial and Open Label Extension".AMERICAN JOURNAL OF GASTROENTEROLOGY 115(2020):S391-S392.